Evidence map›Paper›PMID 41013931›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2025

Stereoselective Syntheses of Cyclic Microsclerodermin Derivatives.

Kevin Bauer, Uli Kazmaier

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kevin BauerOrganic Chemistry, Saarland University, Campus C4.2, 66123, Saarbrücken, Germany.
Uli KazmaierOrganic Chemistry, Saarland University, Campus C4.2, 66123, Saarbrücken, Germany.ORCID https://orcid.org/0000-0001-9756-0589

Funding

Deutsche Forschungsgemeinschaft 447298507
6 · The paper itself

Abstract

Starting from l-xylose and d-arabinose, six different cyclic microscleroderma derivatives were successfully obtained. Key steps of the syntheses are, on the one hand, Sakurai allylations, whose stereochemical course depends on the Lewis acid used, and on the other hand, photochemical Wolff rearrangements in the presence of complex aminofuranosides. Finally, aromatic side chains were introduced via cross metathesis.

Indexed as

Arndt‐Eistert homologationcyclic peptidesmicroscleroderminssakurai reactiontetrahydrofurans

Identifiers

PMID41013931
PMCPMC12559470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.